54 related articles for article (PubMed ID: 21601881)
1. Anti-CA19-9 diabody as a PET imaging probe for pancreas cancer.
Girgis MD; Kenanova V; Olafsen T; McCabe KE; Wu AM; Tomlinson JS
J Surg Res; 2011 Oct; 170(2):169-78. PubMed ID: 21601881
[TBL] [Abstract][Full Text] [Related]
2. Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.
Bading JR; Hörling M; Williams LE; Colcher D; Raubitschek A; Strand SE
Cancer Biother Radiopharm; 2008 Aug; 23(4):399-409. PubMed ID: 18771344
[TBL] [Abstract][Full Text] [Related]
3. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159.
Wang H; Li D; Liu S; Liu R; Yuan H; Krasnoperov V; Shan H; Conti PS; Gill PS; Li Z
J Nucl Med; 2015 Jun; 56(6):908-13. PubMed ID: 25908833
[TBL] [Abstract][Full Text] [Related]
4. Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens.
Khilji SK; Op 't Hoog C; Warschkau D; Lühle J; Goerdeler F; Freitag A; Seeberger PH; Moscovitz O
Theranostics; 2023; 13(9):3041-3063. PubMed ID: 37284439
[TBL] [Abstract][Full Text] [Related]
5. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy.
van Dam MA; Vuijk FA; Stibbe JA; Houvast RD; Luelmo SAC; Crobach S; Shahbazi Feshtali S; de Geus-Oei LF; Bonsing BA; Sier CFM; Kuppen PJK; Swijnenburg RJ; Windhorst AD; Burggraaf J; Vahrmeijer AL; Mieog JSD
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885196
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
Montemagno C; Cassim S; De Leiris N; Durivault J; Faraggi M; Pagès G
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203923
[TBL] [Abstract][Full Text] [Related]
7. Tri-functional platform for construction of modular antibody fragments for
Gamache RF; Zettlitz KA; Tsai WK; Collins J; Wu AM; Murphy JM
Chem Sci; 2020 Jan; 11(7):1832-1838. PubMed ID: 34123276
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography.
González-Gómez R; Pazo-Cid RA; Sarría L; Morcillo MÁ; Schuhmacher AJ
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33801810
[TBL] [Abstract][Full Text] [Related]
9. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
Kumar K; Ghosh A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
[TBL] [Abstract][Full Text] [Related]
10. Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.
Houvast RD; Vankemmelbeke M; Durrant LG; Wuhrer M; Baart VM; Kuppen PJK; de Geus-Oei LF; Vahrmeijer AL; Sier CFM
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371487
[TBL] [Abstract][Full Text] [Related]
11. Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.
Garousi J; Orlova A; Frejd FY; Tolmachev V
EJNMMI Radiopharm Chem; 2020 Jun; 5(1):16. PubMed ID: 32577943
[TBL] [Abstract][Full Text] [Related]
12. Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer.
Lohrmann C; O'Reilly EM; O'Donoghue JA; Pandit-Taskar N; Carrasquillo JA; Lyashchenko SK; Ruan S; Teng R; Scholz W; Maffuid PW; Lewis JS; Weber WA
Clin Cancer Res; 2019 Dec; 25(23):7014-7023. PubMed ID: 31540979
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent contrast agents for tumor surgery.
Xiao Q; Chen T; Chen S
Exp Ther Med; 2018 Sep; 16(3):1577-1585. PubMed ID: 30186374
[TBL] [Abstract][Full Text] [Related]
14. Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.
Tummers WS; Willmann JK; Bonsing BA; Vahrmeijer AL; Gambhir SS; Swijnenburg RJ
Pancreas; 2018 Jul; 47(6):675-689. PubMed ID: 29894417
[TBL] [Abstract][Full Text] [Related]
15. ImmunoPET Imaging of α
White JB; Hu LY; Boucher DL; Sutcliffe JL
Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240
[TBL] [Abstract][Full Text] [Related]
16. Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with
Houghton JL; Abdel-Atti D; Scholz WW; Lewis JS
Mol Pharm; 2017 Mar; 14(3):908-915. PubMed ID: 28191976
[TBL] [Abstract][Full Text] [Related]
17. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM
Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708
[TBL] [Abstract][Full Text] [Related]
18. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
19. Molecular Imaging of Pancreatic Cancer with Antibodies.
England CG; Hernandez R; Eddine SB; Cai W
Mol Pharm; 2016 Jan; 13(1):8-24. PubMed ID: 26620581
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
